Altogether, these data identify a greater abundance of immune checkpoint molecules, an increased maintenance of HIV infection in long-lived CD4 T-cell subsets, and a different responsiveness to IL-7 and IL-15 as key features of and a possible mechanism for suboptimal CD4 T-cell recovery in ART-treated, people with HIV. This evidence concerns the gene CD4 and HIV infectious disease.